Users Provided with an Integrated and Comprehensive View Across Experimental Data and Literature

CUPERTINO, Calif.–NextBio, provider of an innovative platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data, today released an enhanced version of the company’s knowledge discovery platform and products. The NextBio platform is designed to accelerate scientific discoveries and meet the research needs of individual scientists as well as pharmaceutical and biotechnology companies and research institutions seeking to apply NextBio’s capabilities on an enterprise-wide basis.

“We’ve responded to our users’ feedback with a number of enhancements to NextBio, including a new more intuitive user interface, new knowledge discovery and presentation capabilities, and improved community and personalization features,” said Ilya Kupershmidt, NextBio Vice President of Products. “Together, these upgrades to the NextBio platform deliver new levels of ease in searching the vast amounts of public and proprietary data, making new discoveries, and sharing that knowledge with one’s collaborators and peers.”

He noted that included in the new release of NextBio is a novel “recommendation” engine that leverages NextBio’s unique ontologies to recommend studies, literature, clinical trials, and news items to the researcher based on their interests.

“Researchers at The Scripps Research Institute have leveraged NextBio to support and enhance our biomedical research efforts,” said Dr. Jeanne Loring, Professor of Developmental Neurobiology and Director of the Center for Regenerative Medicine. “We are very excited about the new NextBio release, which promises to provide more functionality and improve internal and external knowledge sharing.”

NextBio is now offered in three product versions, each leveraging the NextBio Platform and designed to meet the specific needs of individual scientists or research groups:

NextBio Basic – a free, publicly available web application that allows the researcher to explore the power of NextBio. NextBio Basic provides access to a curated, correlated database of public data, as well as integrated literature, published clinical trials data, scientific news, and community features.

NextBio Professional – designed for the individual researcher or groups of researchers to effectively exploit publicly available and internally generated experimental data to enable and accelerate new scientific discoveries. NextBio Professional lets researchers make real-time discoveries of correlations between genes, pathways, diseases and compounds from a curated repository of experimental data, clinical trials data and literature.

NextBio Enterprise – a completely integrated enterprise version designed for pharmaceutical and biotechnology companies, commercial and non-profit R&D organizations, and academic institutions. NextBio Enterprise combines the features available in NextBio Professional with state-of-the-art security and data protection and an extensive set of APIs, allowing seamless integration into other research systems, workflows and processes.

The NextBio Platform is a robust, fault tolerant, secure and configurable infrastructure that is designed to support an individual researcher or an organization with tens of thousands of employees in locations around the world. The NextBio Platform provides a unique ontology-based semantic framework that connects highly heterogeneous data and textual information.

“The pace of life sciences research is accelerating, with enormous amounts of data being generated each year,” commented Mr. Kupershmidt. “Whether you are an individual scientist or a member of a major company or institution’s R&D efforts, NextBio’s research platform, unique content and products provide an unparalleled way to quickly transform data into new scientific knowledge.”

About NextBio

NextBio is the provider of an innovative platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data. NextBio’s platform seamlessly combines powerful tools with unique correlated content to transform information into knowledge, providing the foundation for new scientific discoveries. NextBio helps organizations increase productivity and dramatically improve collaboration across therapeutic groups and geographic boundaries. NextBio is delivered as a SaaS (Software as a Service) solution resulting in quick deployment and rapid return on investment.

Today, NextBio is used by over a million researchers at the world’s top commercial and academic institutions. NextBio’s enterprise solution has been deployed at Burnham Institute for Medical Research, Celgene, Eli Lilly, Genzyme, Johnson & Johnson, Merck, Regeneron, Scripps Research Institute, Stanford University, and Takeda, among many others. To learn more about NextBio, please visit our website at https://www.nextbio.com.